BioLife Solutions, Inc. (BLFS)
37.31
+0.12
(+0.32%)
USD |
NASDAQ |
Aug 25, 14:24
BioLife Solutions Price to Book Value : 4.343 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.329 |
| August 21, 2026 | 4.318 |
| August 20, 2026 | 4.303 |
| August 19, 2026 | 4.245 |
| August 18, 2026 | 4.067 |
| August 17, 2026 | 4.126 |
| August 14, 2026 | 4.082 |
| August 13, 2026 | 4.101 |
| August 12, 2026 | 4.071 |
| August 11, 2026 | 4.053 |
| August 10, 2026 | 4.032 |
| August 07, 2026 | 4.034 |
| August 06, 2026 | 3.950 |
| August 05, 2026 | 3.934 |
| August 04, 2026 | 3.785 |
| August 03, 2026 | 3.742 |
| July 31, 2026 | 3.641 |
| July 30, 2026 | 3.683 |
| July 29, 2026 | 3.667 |
| July 28, 2026 | 3.722 |
| July 27, 2026 | 3.468 |
| July 24, 2026 | 3.490 |
| July 23, 2026 | 3.582 |
| July 22, 2026 | 3.626 |
| July 21, 2026 | 3.398 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.386 |
| July 17, 2026 | 3.393 |
| July 16, 2026 | 3.522 |
| July 15, 2026 | 3.393 |
| July 14, 2026 | 3.335 |
| July 13, 2026 | 3.271 |
| July 10, 2026 | 3.280 |
| July 09, 2026 | 3.286 |
| July 08, 2026 | 3.165 |
| July 07, 2026 | 3.251 |
| July 06, 2026 | 3.235 |
| July 02, 2026 | 3.272 |
| July 01, 2026 | 3.316 |
| June 30, 2026 | 3.287 |
| June 29, 2026 | 3.712 |
| June 26, 2026 | 3.761 |
| June 25, 2026 | 3.607 |
| June 24, 2026 | 3.354 |
| June 23, 2026 | 3.252 |
| June 22, 2026 | 3.266 |
| June 18, 2026 | 3.416 |
| June 17, 2026 | 3.355 |
| June 16, 2026 | 3.458 |
| June 15, 2026 | 3.501 |
| June 12, 2026 | 3.424 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Repligen Corp. | 4.865 |
| Agilent Technologies, Inc. | 6.137 |
| Danaher Corp. | 2.872 |
| Thermo Fisher Scientific, Inc. | 4.401 |
| West Pharmaceutical Services, Inc. | 8.268 |
Price to Book Value Related Metrics
| PE Ratio | 38.58 |
| PS Ratio | 17.81 |
| Price to Free Cash Flow | 229.22 |
| Price | 37.31 |
| Earnings Yield | 2.59% |
| Market Cap | 1.824B |
| Operating PE Ratio | 614.14 |
| Normalized PE Ratio | 38.58 |